Journal of Clinical Pharmacy & Therapeutics

Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists
pp. 409-419(11)
Authors: Lindenmeyer, A.; Hearnshaw, H.; Vermeire, E.; Van Royen, P.; Wens, J.; Biot, Y.

Effectiveness of raloxifene on bone mineral density and serum lipid levels in post-menopausal women with low BMD after discontinuation of hormone replacement therapy
pp. 421-427(7)
Authors: Song, E. K.; Yeom, J.-H.; Shin, H. T.; Kim, S. H.; Shin, W. G.; Oh, J. M.

A retrospective study to determine the impact of medical- and lifestyle-based contraindications to a prescribed HAART regimen on clinical outcomes and adherence
pp. 429-439(11)
Authors: Lal, L. S.; Grimes, R. M.; Swint, J. M.; Risser, J.

2′-,5′-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
pp. 441-446(6)
Authors: Kim, K.-I.; Kim, S.-R.; Sasase, N.; Taniguchi, M.; Harada, S.; Kinoshita, K.; Kim, S.-H.; Akimoto, Y.; Shikata, M.; Kimura, N.; Izawa, S.; Ohtani, A.; Nakao, K.; Motojima, M.; Kinoshita, M.; Hirai, M.; Ohzu, M.; Hirooka, T.; Nabeshima, S.; Ishii, F.; Tanaka, K.; Hotta, H.

Population pharmacokinetic parameters of vancomycin in critically ill patients
pp. 447-454(8)
Authors: Llopis-Salvia, P.; Jiménez-Torres, N. V.

Hospital-acquired venous thromboembolism and prophylaxis in an integrated hospital delivery system
pp. 455-459(5)
Authors: Dorfman, M.; Chan, S. B.; Maslowski, C.

Age-related changes in consultations and antibiotic prescribing for acute respiratory infections, 1995-2000. Data from the UK General Practice Research Database
pp. 461-467(7)
Authors: Ashworth, M.; Charlton, J.; Latinovic, R.; Gulliford, M.

Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans
pp. 469-476(8)
Authors: Yun, H.-Y.; Park, H.-C.; Kang, W.; Kwon, K.-I.

A six-year evaluation of methadone prescribing practices at a substance misuse treatment centre in the UK
pp. 477-484(8)
Authors: Dickinson, G. L.; Rostami-Hodjegan, A.; Lagundoye, O.; Seivewright, N.; Pratt, P.; Lennard, M. S.

Medication management at home: medication risk factor prevalence and inter-relationships
pp. 485-491(7)
Authors: Sorensen, L.; Stokes, J. A.; Purdie, D. M.; Woodward, M.; Roberts, M. S.

CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine
pp. 493-502(10)
Authors: Shams, M. E. E.; Arneth, B.; Hiemke, C.; Dragicevic, A.; Müller, M. J.; Kaiser, R.; Lackner, K.; Härtter, S.

Cost comparison of epoetin alpha, epoetin beta and darbepoetin alpha for cancer patients with anaemia in the clinical practice setting
pp. 503-512(10)
Author: Reichardt, B.

Enoxaparin-induced alopecia in patients with cerebral venous thrombosis
pp. 513-517(5)
Authors: Wang, Y.-Y.; Po, H. L.